ANalytica's (ALT) 4e is out and confirms that meaningful sales are yet to be booked so cash flows for current quarter won't be coming from here for MLA. However they do state board and management remains confident of financial position etc. hopefully testing phase in hospitals will lead to sales soon and this is what they can see that gives them confidence.
Not sure I agree with view of new lows for MLA but will wait and see.
DYOR, IMO etc
MLA Price at posting:
14.0¢ Sentiment: LT Buy Disclosure: Held